Dipeptidyl Peptidase
Dipeptidyl Peptidase(二肽基肽酶)
Dipeptidyl Peptidase (DPP) is an antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation,signal transduction and apoptosis. DPP is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPP are proline-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPP plays a major role in glucose metabolism. DPP is responsible for the degradation of incretins such as GLP-1. Furthermore, DPP appears to work as a suppressor in the development of cancer and tumours. DPP plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others.
Dipeptidyl Peptidase 相关产品(49)
- GC10018Talabostat mesylateCAS: 150080-09-4纯度: >99.00%
Talabostat (PT100)是一种口服活性和非选择性二肽基肽酶IV(DPP-IV)抑制剂(IC50 < 4 nM; Ki = 0.18 nM)和成纤维细胞活化蛋白(FAP)的第一种临床抑制剂(IC50 = 560 nM),抑制DPP 8/9(IC50= 4/11 nM; Ki = 1.5/0.76 nM),静止细胞脯氨酸二肽酶(QPP)( IC50= 310 nM),DPP 2和其他一些DASH家族酶。
- GC10298Sitagliptin phosphate monohydrateCAS: 654671-77-9纯度: >99.50%
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) 是一种有效的 DPP4 抑制剂,在 Caco-2 细胞提取物中的 IC50 为 19 nM。
- GC12895SaxagliptinCAS: 361442-04-8纯度: >99.50%
Saxagliptin是一种高效二肽基肽酶-4(DPP-4)抑制剂,通过选择性抑制DPP-4酶,从而升高内源性胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性促胰岛素释放多肽(GIP)的水平以调节血糖。
- GC15130Alogliptin (SYR-322)CAS: 850649-61-5纯度: >98.00% / >99.00%
Alogliptin (SYR-322) (SYR-322 free base) 是一种有效的、选择性的、具有口服活性的 DPP-4 抑制剂,IC50 <10 nM,选择性比 DPP-8 和 DPP-9 高 10,000 倍以上.
- GC30877DPP-IV-IN-2CAS: 136259-18-2纯度: >98.00%
DPP-IV-IN-2是二肽基肽酶IV(DPIV)和DP8/9的抑制剂,其IC50值分别为0.1和0.95μM。
- GC31317Sitagliptin (MK0431)CAS: 486460-32-6纯度: >99.50%
Sitagliptin (MK0431) 是一种口服、高选择性的二肽基肽酶-4(DPP-4)抑制剂,IC 50 为18nM。
- GC31333Teneligliptin (MP-513)CAS: 760937-92-6纯度: >99.50%
Teneliligliptin (MP-513) (MP-513) 是一种有效的、可口服的、有竞争力的、长效的 DPP-4 抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10018 | Talabostat mesylate | 150080-09-4 | >99.00% | |
Talabostat (PT100)是一种口服活性和非选择性二肽基肽酶IV(DPP-IV)抑制剂(IC50 < 4 nM; Ki = 0.18 nM)和成纤维细胞活化蛋白(FAP)的第一种临床抑制剂(IC50 = 560 nM),抑制DPP 8/9(IC50= 4/11 nM; Ki = 1.5/0.76 nM),静止细胞脯氨酸二肽酶(QPP)( IC50= 310 nM),DPP 2和其他一些DASH家族酶。 | ||||
| GC10091 | Nateglinide | 105816-04-4 | >99.50% | |
A hypoglycemic agent | ||||
| GC10171 | Puromycin aminonucleoside | 58-60-6 | >98.00% | |
A glomerular epithelial cell toxin | ||||
| GC10298 | Sitagliptin phosphate monohydrate | 654671-77-9 | >99.50% | |
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) 是一种有效的 DPP4 抑制剂,在 Caco-2 细胞提取物中的 IC50 为 19 nM。 | ||||
| GC12235 | Sitagliptin (phosphate) | 654671-78-0 | >98.00% | |
A DPP-4 inhibitor | ||||
| GC12360 | UAMC 00039 dihydrochloride | 697797-51-6 | >99.50% | |
A potent DPP-2 inhibitor | ||||
| GC12895 | Saxagliptin | 361442-04-8 | >99.50% | |
Saxagliptin是一种高效二肽基肽酶-4(DPP-4)抑制剂,通过选择性抑制DPP-4酶,从而升高内源性胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性促胰岛素释放多肽(GIP)的水平以调节血糖。 | ||||
| GC13949 | Alogliptin Benzoate | 850649-62-6 | >99.50% | |
A DPP-4 inhibitor | ||||
| GC14827 | Linagliptin (BI-1356) | 668270-12-0 | >99.50% | |
A potent DPP-4 inhibitor | ||||
| GC15130 | Alogliptin (SYR-322) | 850649-61-5 | >98.00% / >99.00% | |
Alogliptin (SYR-322) (SYR-322 free base) 是一种有效的、选择性的、具有口服活性的 DPP-4 抑制剂,IC50 <10 nM,选择性比 DPP-8 和 DPP-9 高 10,000 倍以上. | ||||
| GC15576 | Teneligliptin hydrobromide | 906093-29-6 | >99.50% | |
A DPP-4 inhibitor | ||||
| GC16613 | Trelagliptin | 865759-25-7 | >99.50% | |
A DDP-4 inhibitor | ||||
| GC16733 | Vildagliptin (LAF-237) | 274901-16-5 | >98.00% | |
A DPP-4 inhibitor | ||||
| GC17012 | MK3102 | 1226781-44-7 | >99.00% | |
MK3102 (Omarigliptin)是一种新型的每周一次的二肽基肽酶-4 (DPP-4)抑制剂(IC50: 2.2 nM),用于治疗2型糖尿病。 | ||||
| GC17479 | Trelagliptin succinate | 1029877-94-8 | >99.50% | |
A DDP-4 inhibitor | ||||
| GC19052 | AZD7986 | 1802148-05-5 | >99.00% | |
An inhibitor of DPP-1 | ||||
| GC19120 | DBPR108 | 1186426-66-3 | >99.50% | |
DBPR108 是一种有效的、选择性的、口服生物可利用的二肽衍生的 DPP4 抑制剂,IC50 为 15 nM。对 DDP8 和 DPP9 无抑制作用。 | ||||
| GC30877 | DPP-IV-IN-2 | 136259-18-2 | >98.00% | |
DPP-IV-IN-2是二肽基肽酶IV(DPIV)和DP8/9的抑制剂,其IC50值分别为0.1和0.95μM。 | ||||
| GC31317 | Sitagliptin (MK0431) | 486460-32-6 | >99.50% | |
Sitagliptin (MK0431) 是一种口服、高选择性的二肽基肽酶-4(DPP-4)抑制剂,IC 50 为18nM。 | ||||
| GC31333 | Teneligliptin (MP-513) | 760937-92-6 | >99.50% | |
Teneliligliptin (MP-513) (MP-513) 是一种有效的、可口服的、有竞争力的、长效的 DPP-4 抑制剂。 | ||||
| GC31341 | Anagliptin (SK-0403) | 739366-20-2 | - | |
A DPP-4 inhibitor | ||||
| GC31414 | Diprotin A TFA (Ile-Pro-Pro (TFA)) | 209248-71-5 | >98.50% | |
A tripeptide inhibitor of DPP-4 | ||||
| GC31444 | Saikogenin A | 5092-09-1 | >98.00% | |
SaikogeninA可从中药柴胡中提取,是一种二肽基肽酶IV(DPP-IV)抑制剂。 | ||||
| GC31463 | Gosogliptin (PF-00734200) | 869490-23-3 | >98.50% | |
An inhibitor of DPP-4 | ||||
